Terlivaz (terlipressin): the first FDA-approved treatment for HRS in adults with rapid reduction in kidney function

Name: Terlivaz (terlipressin): the first FDA-approved treatment for HRS in adults with rapid reduction in kidney function
Start: 2025-09-08T21:00:00-04:00
End: 2025-09-08T23:00:00-04:00
Location: Finch & Fork

Finch & Fork
31 West Carrillo Street
Santa Barbara, CA 93101

Monday, September 8, 2025 at 6:00pm PT - 8:00pm PT
Add this event to your calendar

Info
Speakers
Agenda

Info

Topic

Terlivaz

Additional Information

Discussion of the pathophysiology of hepatorenal syndrome, associated burden of disease and current recommendations on diagnosis and treatment. Includes clinical data that led to the FDA approval of TERLIVAZ.

Speakers

Sammy Saab MD, AGAF

Director
Pfleger Liver Institute
UCLA

Event Agenda

Attachments

AACN Santa Barbara County Chapter_Event_Event (560 KB)